Breaking News Instant updates and real-time market news.

CBAY

CymaBay

$12.81

-0.535 (-4.01%)

04:55
05/01/19
05/01
04:55
05/01/19
04:55

CymaBay management to meet with Piper Jaffray

Meeting to be held in San Francisco on May 1 hosted by Piper Jaffray.

  • 01

    May

  • 06

    May

  • 08

    May

CBAY CymaBay
$12.81

-0.535 (-4.01%)

02/20/19
PIPR
02/20/19
NO CHANGE
Target $30
PIPR
Overweight
'Underwhelming' Intercept data hurts CymaBay bear thesis, says Piper Jaffray
One of the major constituents of the CymaBay Therapeutics (CBAY) bear thesis has been that pricing for Intercept Pharmaceuticals' (ICPT) Ocaliva would get cut significantly with success in nonalcoholic steatohepatitis and consequently lower the eventual market opportunity for CymaBay's seladelapar in primary biliary cholangitis, Piper Jaffray analyst Tyler Van Buren tells investors in a research note. The analyst, however, believes Intercept's Ocaliva data in NASH yesterday was "underwhelming" as the "fibrosis improvement was mild, no significant effect on NASH was observed, and worrisome safety and tolerability issues remain." Questions regarding the commercial viability of Ocaliva in NASH are now likely to persist, says Van Buren. He now believes Intercept will have to target the most severe patients, "significantly narrowing" the drug's addressable population. This should lead to more stable Ocaliva pricing than many currently assume and keep seladelpar's $750M-plus market opportunity in PBC "largely" intact, contends the analyst. Bottom line is that a major constituent of the CymaBay bear thesis has now been removed, he writes. Van Buren keeps an Overweight rating on the shares with a $30 price target. CymaBay Therapeutics closed yesterday up 34c to $10.29.
02/22/19
LEER
02/22/19
INITIATION
Target $22
LEER
Outperform
CymaBay initiated with an Outperform at SVB Leerink
SVP Leerink analyst Pasha Sarraf initiated CymaBay with an Outperform rating and $22 price target, telling investors in a research note that the company is demonstrating "impressive" efficacy and safety profile in PBC and pre-clinically in NASH. Sarraf says he is positive on the immunology sector with its diverse indications, continuous innovation, and deep expertise, and is looking long for opportunities in challenging immuno-metabolism and metabolism sectors, in areas like NASH, obesity and diabetes.
03/01/19
PIPR
03/01/19
NO CHANGE
Target $30
PIPR
Overweight
Piper Jaffray loves the setup for CymaBay shares into NASH data
CymaBay's Seladelpar has made "tremendous progress" in primary biliary cholangitis over the past year its competitive positioning continues to improve, Piper Jaffray analyst Tyler Van Buren tells investors in a research note. Further, the analyst believes the drug's nonalcoholic steatohepatitis opportunity is not currently being factored into the existing valuation. The analyst expects to receive topline data from the ongoing Phase IIb trial of seladelpar in NASH next quarter. If successful, it could "multiply" the $750M PBC opportunity in his model, Van Buren says in a research note titled "We Love The Setup Of CBAY Here; Reiterate The Overweight." He keeps a $30 price target on CymaBay shares.
04/15/19
CANT
04/15/19
NO CHANGE
Target $20
CANT
Overweight
Genfit data show CymaBay may be differentiated, says Cantor Fitzgerald
Further competitor primary biliary cholangitis data from Genfit's (GNFTF) elafibranor suggest CymaBay Therapeutics' (CBAY) seladelpar may have a differentiated profile, Cantor Fitzgerald analyst Eliana Merle tells investors in a research note. The analyst keeps an Overweight rating on CymaBay with a $20 price target.

TODAY'S FREE FLY STORIES

MAT

Mattel

$11.62

0.21 (1.84%)

09:55
06/20/19
06/20
09:55
06/20/19
09:55
Options
Mattel put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORCL

Oracle

$56.35

3.66 (6.95%)

, DO

Diamond Offshore

$8.49

0.38 (4.69%)

09:55
06/20/19
06/20
09:55
06/20/19
09:55
Options
Early notable gainers among liquid option names on June 20th »

Notable gainers among…

ORCL

Oracle

$56.35

3.66 (6.95%)

DO

Diamond Offshore

$8.49

0.38 (4.69%)

REGN

Regeneron

$322.40

10.65 (3.42%)

RIG

Transocean

$6.27

0.29 (4.85%)

RRC

Range Resources

$6.97

0.155 (2.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

09:55
06/20/19
06/20
09:55
06/20/19
09:55
General news
U.S. leading index preview: the index »

U.S. leading index…

POR

Portland General Electric

$55.86

0.255 (0.46%)

, PCG

PG&E

$20.98

0.47 (2.29%)

09:55
06/20/19
06/20
09:55
06/20/19
09:55
Conference/Events
The Federal Energy Regulatory Commission (FERC) to hold a meeting »

Open Commission Meeting…

POR

Portland General Electric

$55.86

0.255 (0.46%)

PCG

PG&E

$20.98

0.47 (2.29%)

ALE

Allete

$85.81

0.53 (0.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

  • 21

    Jun

CODI

Compass Diversified

$19.10

0.35 (1.87%)

09:52
06/20/19
06/20
09:52
06/20/19
09:52
Conference/Events
Compass Diversified to host investor & analyst meeting »

Investor & Analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

S

Sprint

$7.50

0.04 (0.54%)

, TMUS

T-Mobile

$78.88

0.6 (0.77%)

09:48
06/20/19
06/20
09:48
06/20/19
09:48
Periodicals
T-Mobile, Sprint highly likely to receive DOJ approval, CNBC reports »

T-Mobile (TMUS) and…

S

Sprint

$7.50

0.04 (0.54%)

TMUS

T-Mobile

$78.88

0.6 (0.77%)

DISH

Dish

$39.51

0.61 (1.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CUK

Carnival plc

$45.66

-6.08 (-11.75%)

09:47
06/20/19
06/20
09:47
06/20/19
09:47
Hot Stocks
Carnival plc falls -11.6% »

Carnival plc is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

PIR

Pier 1 Imports

$11.89

11.2159 (1,663.83%)

09:47
06/20/19
06/20
09:47
06/20/19
09:47
Hot Stocks
Pier 1 Imports falls -12.3% »

Pier 1 Imports is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

JDST

Direxion Daily Junior Gold Miners Index Bear 3x Shares

$29.80

-4.41 (-12.89%)

09:47
06/20/19
06/20
09:47
06/20/19
09:47
Hot Stocks
Direxion Daily Junior Gold Miners Index Bear 3x Shares falls -12.9% »

Direxion Daily Junior…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IAG

IAMGold

$3.36

0.35 (11.63%)

09:47
06/20/19
06/20
09:47
06/20/19
09:47
Hot Stocks
IAMGold rises 12.0% »

IAMGold is up 12.0%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZNH

China Southern Airlines

$35.85

2.24 (6.66%)

09:47
06/20/19
06/20
09:47
06/20/19
09:47
Hot Stocks
China Southern Airlines rises 7.4% »

China Southern Airlines…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNUG

Direxion Daily Jr Gld Mnrs Bull 3X Shrs

$10.99

1.29 (13.30%)

09:47
06/20/19
06/20
09:47
06/20/19
09:47
Hot Stocks
Direxion Daily Jr Gld Mnrs Bull 3X Shrs rises 12.8% »

Direxion Daily Jr Gld…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZSAN

Zosano Pharma

$3.07

(0.00%)

09:45
06/20/19
06/20
09:45
06/20/19
09:45
Conference/Events
Zosano Pharma management to meet with Maxim »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

  • 25

    Jun

09:45
06/20/19
06/20
09:45
06/20/19
09:45
General news
Leading Indicators to be reported at 10:00 »

May Leading Indicators…

S

Sprint

$7.46

(0.00%)

, TMUS

T-Mobile

$78.28

(0.00%)

09:44
06/20/19
06/20
09:44
06/20/19
09:44
Periodicals
Breaking Periodicals news story on Sprint, T-Mobile »

Sprint, T-Mobile highly…

S

Sprint

$7.46

(0.00%)

TMUS

T-Mobile

$78.28

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PHUN

Phunware

$3.50

(0.00%)

09:44
06/20/19
06/20
09:44
06/20/19
09:44
Hot Stocks
Phunware says Phun utility tokens now available in select international markets »

Phunware announced Phun…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WYND

Wyndham Destinations

$43.19

(0.00%)

09:43
06/20/19
06/20
09:43
06/20/19
09:43
Conference/Events
Wyndham Destinations management to meet with SunTrust »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 26

    Jun

VKTX

Viking Therapeutics

$8.22

(0.00%)

09:41
06/20/19
06/20
09:41
06/20/19
09:41
Conference/Events
Viking Therapeutics management to meet with SunTrust »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 26

    Jun

EVBG

Everbridge

$91.34

(0.00%)

09:40
06/20/19
06/20
09:40
06/20/19
09:40
Recommendations
Everbridge analyst commentary at SunTrust »

Everbridge price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AOBC

American Outdoor Brands

$9.17

(0.00%)

, MLNT

Melinta Therapeutics

$6.30

(0.00%)

09:40
06/20/19
06/20
09:40
06/20/19
09:40
Options
Unusually active option classes on open June 20th »

Unusual total active…

AOBC

American Outdoor Brands

$9.17

(0.00%)

MLNT

Melinta Therapeutics

$6.30

(0.00%)

PAAS

Pan American Silver

$11.78

(0.00%)

AUY

Yamana Gold

$2.23

(0.00%)

GDXJ

VanEck Vectors Junior Gold Miners

$32.36

(0.00%)

ESV

Ensco Rowan

$7.35

(0.00%)

NEM

Newmont Mining

$36.36

(0.00%)

KR

Kroger

$23.64

(0.00%)

JNUG

Direxion Daily Jr Gld Mnrs Bull 3X Shrs

$9.70

(0.00%)

XLNX

Xilinx

$111.85

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

  • 27

    Jun

  • 09

    Jul

UPS

UPS

$101.55

(0.00%)

09:40
06/20/19
06/20
09:40
06/20/19
09:40
Conference/Events
UPS management to meet with KeyBanc »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 26

    Jun

  • 24

    Jul

CBS

CBS

$49.72

0.51 (1.04%)

, VIA

Viacom

$35.68

0.85 (2.44%)

09:39
06/20/19
06/20
09:39
06/20/19
09:39
Periodicals
CBS, Viacom expect merger deal in near term, CNBC's Faber reports »

While CBS (CBS) and…

CBS

CBS

$49.72

0.51 (1.04%)

VIA

Viacom

$35.68

0.85 (2.44%)

VIAB

Viacom

$30.46

0.65 (2.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 08

    Aug

  • 08

    Aug

  • 08

    Aug

VTR

Ventas

$69.65

1.05 (1.53%)

09:37
06/20/19
06/20
09:37
06/20/19
09:37
Recommendations
Ventas analyst commentary at RBC Capital »

Ventas price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBS

CBS

$49.72

0.51 (1.04%)

, VIA

Viacom

$35.68

0.85 (2.44%)

09:37
06/20/19
06/20
09:37
06/20/19
09:37
Periodicals
Breaking Periodicals news story on CBS, Viacom, Viacom »

CBS, Viacom not…

CBS

CBS

$49.72

0.51 (1.04%)

VIA

Viacom

$35.68

0.85 (2.44%)

VIAB

Viacom

$30.46

0.65 (2.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 08

    Aug

  • 08

    Aug

  • 08

    Aug

TSLX

TPG Specialty Lending

$20.20

0.24 (1.20%)

09:37
06/20/19
06/20
09:37
06/20/19
09:37
Conference/Events
TPG Specialty Lending management to meet with JMP Securities »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 26

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.